BioGaia AB

LSE : 0GTN

BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pyloriย–the gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. The company sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Type
Common Stock
Country
Sweden

Price

SEK 115.20

Symbol

0GTN

Type

Common Stock

Previous Close

:

116.10

52 Week Range

:

93.65 - 136.50

Volume

:

0.00

Average Volume

:

1,507.00

High

:

116.10

Low

:

115.20

Change

:

-0.90

Percent change (%)

:

-0.78

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...